Details for New Drug Application (NDA): 204362
✉ Email this page to a colleague
The generic ingredient in EPTIFIBATIDE is eptifibatide. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the eptifibatide profile page.
Summary for 204362
Tradename: | EPTIFIBATIDE |
Applicant: | Usv |
Ingredient: | eptifibatide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
Approval Date: | Mar 11, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription